JAMA Network Open,
Journal Year:
2020,
Volume and Issue:
3(4), P. e202149 - e202149
Published: April 7, 2020
Importance
Long
noncoding
RNAs
(lncRNAs)
are
involved
in
innate
and
adaptive
immunity
cancer
by
mediating
the
functional
state
of
immunologic
cells,
pathways,
genes.
However,
whether
lncRNAs
associated
with
immune
molecular
classification
clinical
outcomes
immunotherapy
is
largely
unknown.
Objectives
To
explore
lncRNA-based
subtypes
survival
response
to
present
a
novel
lncRNA
score
for
prediction
using
computational
algorithms.
Design,
Setting,
Participants
In
this
cohort
study,
an
individual
patient
analysis
based
on
phase
2,
single-arm
trial
multicohort
was
performed
from
June
25
through
September
30,
2019.
Data
2
IMvigor210
The
Cancer
Genome
Atlas
(TCGA).
study
analyzed
genomic
data
348
patients
bladder
71
melanoma
TCGA
who
were
treated
immunotherapy.
addition,
pancancer
that
included
2951
obtained
TCGA.
Main
Outcomes
Measures
primary
end
point
overall
(OS).
Results
Among
(272
[78.2%]
male)
(mean
[SD]
age,
58.3
[13.4]
years;
37
[52.1%]
female),
4
distinct
classes
statistically
significant
differences
OS
(median
months,
not
reached
vs
9.6
8.1
6.7
months;P
=
.002)
identified.
greatest
benefit
immune-active
class,
as
characterized
immune-functional
signature
high
CTL
infiltration.
Patients
low
scores
had
significantly
longer
(hazard
ratio,
0.32;
95%
CI,
0.24-0.42;P
<
.001)
across
various
types.
immunotherapeutic
(area
under
curve
[AUC],
0.79
at
12
months
0.77
20
months)
(AUC,
0.87
24
months),
superior
tumor
alteration
burden,
programmed
cell
death
ligand
1
(PD-L1)
expression,
cytotoxic
T-lymphocyte
(CTL)
Addition
combination
PD-L1
infiltration
build
multiomics
algorithm
correlated
more
strongly
0.81
0.80
months).
Conclusions
Relevance
This
identifies
recommends
class.
should
be
integrated
into
multiomic
panels
precision
Genome Medicine,
Journal Year:
2019,
Volume and Issue:
11(1)
Published: Aug. 28, 2019
Neoantigens
are
newly
formed
peptides
created
from
somatic
mutations
that
capable
of
inducing
tumor-specific
T
cell
recognition.
Recently,
researchers
and
clinicians
have
leveraged
next
generation
sequencing
technologies
to
identify
neoantigens
create
personalized
immunotherapies
for
cancer
treatment.
To
a
vaccine,
must
be
computationally
predicted
matched
tumor-normal
data,
then
ranked
according
their
capability
in
stimulating
response.
This
candidate
neoantigen
prediction
process
involves
multiple
steps,
including
mutation
identification,
HLA
typing,
peptide
processing,
peptide-MHC
binding
prediction.
The
general
workflow
has
been
utilized
many
preclinical
clinical
trials,
but
there
is
no
current
consensus
approach
few
established
best
practices.
In
this
article,
we
review
recent
discoveries,
summarize
the
available
computational
tools,
provide
analysis
considerations
each
step,
prediction,
prioritization,
delivery,
validation
methods.
addition
reviewing
state
analysis,
practical
guidance,
specific
recommendations,
extensive
discussion
critical
concepts
points
confusion
practice
characterization
use.
Finally,
outline
necessary
areas
development,
need
improve
class
II
typing
accuracy,
expand
software
support
diverse
sources,
incorporate
response
data
algorithms.
ultimate
goal
workflows
vaccines
patient
outcomes
types.
Theranostics,
Journal Year:
2020,
Volume and Issue:
11(5), P. 2201 - 2217
Published: Dec. 16, 2020
Recent
studies
have
highlighted
the
biological
significance
of
RNA
N6-methyladenosine
(m6A)
modification
in
tumorigenicity
and
progression.
However,
it
remains
unclear
whether
m6A
modifications
also
potential
roles
immune
regulation
tumor
microenvironment
(TME)
formation.
Methods:
In
this
study,
we
curated
23
regulators
performed
consensus
molecular
subtyping
with
NMF
algorithm
to
determine
patterns
m6A-related
gene
signature
colon
cancer
(CC).
The
ssGSEA
CIBERSORT
algorithms
were
employed
quantify
relative
infiltration
levels
various
cell
subsets.
An
PCA
based
m6Sig
scoring
scheme
was
used
evaluate
individual
tumors
an
response.
Results:
Three
distinct
identified
among
1307
CC
samples,
which
associated
different
clinical
outcomes
pathways.
TME
characterization
revealed
that
highly
consistent
three
known
profiles:
immune-inflamed,
immune-excluded,
immune-desert,
respectively.
Based
on
score,
extracted
from
genes,
patients
can
be
divided
into
high
low
score
subgroups.
Patients
lower
characterized
by
prolonged
survival
time
enhanced
infiltration.
Further
analysis
indicated
correlated
greater
mutation
loads,
PD-L1
expression,
higher
rates
SMGs
(e.g.,
PIK3CA
SMAD4).
addition,
scores
showed
a
better
responses
durable
benefits
independent
immunotherapy
cohorts.
Conclusions:
This
study
highlights
is
significantly
diversity
complexity.
Quantitatively
evaluating
will
strengthen
our
understanding
characteristics
promote
more
effective
strategies.
Frontiers in Immunology,
Journal Year:
2020,
Volume and Issue:
11
Published: June 30, 2020
Background:
The
tumor
microenvironment
(TME)
consists
of
heterogeneous
cell
populations,
including
malignant
cells
and
nonmalignant
that
support
proliferation,
invasion,
metastasis
through
extensive
crosstalk.
intra-tumor
immune
landscape
is
a
critical
factor
influencing
patient
survival
response
to
immunotherapy.
Methods:
Gene
expression
data
were
downloaded
from
Cancer
Genome
Atlas
Expression
Omnibus
databases.
Immune
infiltration
was
determined
by
single-sample
gene
set
enrichment
analysis
(ssGSEA)
depending
on
the
integrated
sets
published
studies.
Univariate
used
determine
prognostic
value
infiltrated
cells.
LASSO
regression
performed
screen
for
most
survival-relevant
An
immune-cell
characteristic
score
(ICCS)
model
constructed
using
multivariate
Cox
analysis.
Results:
patterns
across
32
cancer
types
identified,
patients
in
high
cluster
had
worse
overall
(OS)
but
better
progression-free
interval
(PFI)
compared
low
cluster.
However,
showed
inconsistent
type.
High
indicated
prognosis
LGG,
GBM,
UVM,
favorable
ACC,
CESE,
CHOL,
HNSC,
LIHC,
LUAD,
SARC,
SKCM.
LUAD
significantly
influenced
13
types,
with
all
Th2
correlating
prognosis.
ICCS
based
6
populations
generated
classified
into
low-
high-ICCS
groups
good
poor
respectively.
stratified
further
revealed
an
independent
LUAD.
Conclusions:
quantified
considerable
heterogeneity
observed
relevance
these
different
types.
competent
performance,
which
can
deepen
our
understanding
lung
adenocarcinoma
have
implications
Cancer Research,
Journal Year:
2019,
Volume and Issue:
79(24), P. 6238 - 6246
Published: Oct. 22, 2019
Various
computational
approaches
have
been
developed
for
estimating
the
relative
abundance
of
different
cell
types
in
tumor
microenvironment
(TME)
using
bulk
RNA
data.
However,
a
comprehensive
comparison
across
diverse
datasets
that
objectively
evaluates
performance
these
has
not
conducted.
Here,
we
benchmarked
seven
widely
used
tools
and
gene
sets
introduced
Consensus
Briefings in Bioinformatics,
Journal Year:
2020,
Volume and Issue:
22(3)
Published: March 9, 2020
Abstract
Long
noncoding
RNAs
(lncRNAs)
have
been
associated
with
cancer
immunity
regulation
and
the
tumor
microenvironment
(TME).
However,
functions
of
lncRNAs
tumor-infiltrating
B
lymphocytes
(TIL-Bs)
their
clinical
significance
not
yet
fully
elucidated.
In
present
study,
a
machine
learning-based
computational
framework
is
presented
for
identification
lncRNA
signature
TIL-Bs
(named
‘TILBlncSig’)
through
integrative
analysis
immune,
profiles.
The
TILBlncSig
comprising
eight
(TNRC6C-AS1,
WASIR2,
GUSBP11,
OGFRP1,
AC090515.2,
PART1,
MAFG-DT
LINC01184)
was
identified
from
list
141
B-cell-specific
lncRNAs.
capable
distinguishing
worse
compared
improved
survival
outcomes
across
different
independent
patient
datasets
also
other
covariates.
Functional
characterization
revealed
it
to
be
an
indicator
infiltration
mononuclear
immune
cells
(i.e.
natural
killer
cells,
B-cells
mast
cells),
hallmarks
cancer,
as
well
immunosuppressive
phenotype.
Furthermore,
predictive
value
outcome
immunotherapy
response
patients
anti-programmed
death-1
(PD-1)
therapy
added
significant
power
current
checkpoint
gene
markers.
study
has
highlighted
cell
in
TME
RNA
perspective
strengthened
potential
application
biomarkers
response,
which
warrants
further
investigation.
European Journal of Cancer,
Journal Year:
2021,
Volume and Issue:
149, P. 193 - 210
Published: April 16, 2021
The
rising
interest
for
precise
characterization
of
the
tumour
immune
contexture
has
recently
brought
forward
high
potential
RNA
sequencing
(RNA-seq)
in
identifying
molecular
mechanisms
engaged
response
to
immunotherapy.
In
this
review,
we
provide
an
overview
major
principles
single-cell
and
conventional
(bulk)
RNA-seq
applied
onco-immunology.
We
describe
standard
preprocessing
statistical
analyses
data
obtained
from
such
techniques
highlight
some
computational
challenges
relative
individual
cells.
notably
examples
gene
expression
as
differential
analysis,
dimensionality
reduction,
clustering
enrichment
analysis.
Additionally,
used
public
sets
exemplify
how
deconvolution
algorithms
can
identify
quantify
multiple
subpopulations
either
bulk
or
RNA-seq.
give
machine
deep
learning
models
predict
patient
outcomes
treatment
effect
high-dimensional
data.
Finally,
balance
strengths
weaknesses
regarding
their
applications
clinic.
Annual Review of Pathology Mechanisms of Disease,
Journal Year:
2021,
Volume and Issue:
17(1), P. 425 - 457
Published: Nov. 18, 2021
Chronic
inflammation
increases
the
risk
of
several
cancers,
including
gastric,
colon,
and
hepatic
cancers.
Conversely,
tumors,
similar
to
tissue
injury,
trigger
an
inflammatory
response
coordinated
by
innate
immune
system.
Cellular
molecular
mediators
modulate
tumor
growth
directly
influencing
adaptive
response.
Depending
on
balance
cell
types
signals
within
microenvironment,
can
support
or
restrain
tumor.
Adding
complexity,
research
from
past
two
decades
has
revealed
that
cells
are
highly
heterogeneous
plastic,
with
variable
phenotypes
depending
type,
stage,
treatment.
The
field
is
now
cusp
being
able
harness
this
wealth
data
(
Frontiers in Immunology,
Journal Year:
2019,
Volume and Issue:
10
Published: Sept. 20, 2019
Neutrophils
have
been
extensively
described
in
the
pathophysiology
of
autoimmune
and
infectious
diseases.
Accumulating
evidence
also
suggests
important
role
neutrophils
cancer
progression
through
their
interaction
with
immune
cells
blood
tumor
microenvironment
(TME).
Most
studies
as
key
drivers
progression,
due
to
involvement
various
promoting
functions
including
proliferation,
aggressiveness
dissemination,
well
suppression.
However,
such
were
focusing
on
late-stages
tumorigenesis,
which
chronic
inflammation
had
already
developed.
The
tumor-associated
(TANs)
at
early
stages
development
remains
poorly
described,
though
recent
findings
indicate
that
early-stage
TANs
may
display
anti-tumor
properties.
Beyond
site,
supported
by
NLR
retrospective
functional
analyses
suggest
could
actively
contribute
tumorigenesis.
Hence,
it
appears
phenotype
vary
greatly
during
highlighting
heterogeneity.
origin
pro-
or
is
generally
believed
arise
following
a
change
cell
state,
from
resting
activated.
Moreover,
fate
involve
distinct
differentiation
programs
yielding
subsets
pro
neutrophils.
In
this
review,
we
will
discuss
current
knowledge
heterogeneity
across
different
tissues
impact
neutrophil-based
therapeutic
strategies
shown
promising
results
pre-clinical
studies,
paving
way
for
design
next
generation
immunotherapy.